vanadium pentoxide has been researched along with Thromboembolism in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colin-Barenque, L; Diaz-Bech, ME; Fortoul, TI; González-Villalva, A; Martinez-Pedraza, M; Montaño, LF; Mussali-Galante, P; Piñón-Zarate, G; Rodriguez-Lara, V | 1 |
1 other study(ies) available for vanadium pentoxide and Thromboembolism
| Article | Year |
|---|---|
Spleen and bone marrow megakaryocytes as targets for inhaled vanadium.
Topics: Animals; Bone Marrow Cells; Cell Proliferation; Cell Size; Inhalation Exposure; Male; Megakaryocytes; Mice; Models, Animal; Particulate Matter; Spleen; Thromboembolism; Thrombopoiesis; Time Factors; Vanadium Compounds | 2008 |